Kenvue (KVUE) Insider Granted Options & RSUs for 534k Shares
Kenvue Inc.
Subscribe to track KVUE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Kenvue Insider Granted Equity Package
Company: Kenvue Inc. (KVUE) Form: 4 | Filed: 2025-12-17 Significance: Low
Insider: De Jesus Carlos Title: Group President North America | Relationship: Officer
Transaction: • Type: Grant (Code A) • Shares: 534,712 (underlying total: 483,870 Options & 50,842 RSUs) • Price: $0.00 • Value: Not specified (Grant) • Owned After: 534,712 (derivative securities)
Key Insight: A routine executive compensation grant representing a minimal potential dilution of ~0.03% of estimated shares outstanding. The awards vest over three years, aligning executive and shareholder interests.
Market Context: This is a standard equity award for a large-cap company ($31.92B market cap) and is not indicative of a shift in insider sentiment.
Comprehensive Analysis
SEC Filing Analysis: Kenvue Inc. (KVUE)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Group President of North America received a standard equity compensation package, consisting of stock options and restricted stock units (RSUs), representing a minimal potential dilution to shareholders.
- Market Impact: Neutral. This is a routine, non-market transaction typical for executive compensation in a large-cap company.
Company Information
| Field | Value |
|---|---|
| Company | Kenvue Inc. |
| Ticker Symbol | KVUE |
| CIK | 0001944048 |
| Industry | Perfumes, Cosmetics & Other Toilet Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | De Jesus Carlos |
| CIK | 0002094464 |
| Title/Position | Group President North America |
| Relationship | Officer |
Transaction Details
This filing reports two separate derivative grants:
- Restricted Stock Units (RSUs): 50,842 units.
- Stock Options: 483,870 options with an exercise price of $17.21.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-15 |
| Transaction Code | A (Grant) |
| Security Type | Stock Options and Restricted Stock Units |
| Shares Involved | 534,712 (Total underlying shares) |
| Price Per Share | $0.00 (Price paid for grant) |
| Total Value | Not applicable for grants |
| Shares Owned After | 534,712 (in derivative securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
Note: Shares Outstanding was not provided and is estimated for analysis by dividing market cap by the option exercise price ($31.92B / $17.21 ≈ 1.85B shares).
| Metric | Value |
|---|---|
| Transaction Value | $0 (Grant transaction price) |
| % of Market Cap | ~0.0% |
| Shares Transacted | 534,712 (underlying shares) |
| % of Shares Outstanding | ~0.029% (Estimated) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Kenvue is a large-cap company with a market capitalization of $31.92 billion. This equity grant is immaterial relative to the company's total valuation.
- Dilution Impact: The 534,712 shares underlying these grants represent a potential dilution of approximately 0.029% of estimated outstanding shares. This is a negligible impact on existing shareholders.
- Transaction Significance: The transaction's significance is low. It is not an open-market purchase or sale, but a pre-planned component of executive compensation designed to incentivize performance and retention.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants are a standard form of compensation and do not typically influence short-term stock price. They are expected by the market and priced into compensation models.
Volume & Sentiment
- Expected Volume Impact: None. This was not an open-market transaction.
- Sentiment Indicator: Neutral. This filing provides no new information to alter market sentiment towards the stock.
Additional Context
Transaction Notes
- Vesting Schedule: Both the RSU and Stock Option awards vest in three equal annual installments beginning on December 1, 2026. This multi-year vesting schedule aligns the executive's long-term interests with those of shareholders.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
